Skip to main content
Top
Published in: Current Bladder Dysfunction Reports 3/2021

01-09-2021 | Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Understanding the FDA Device Approval Process in FPMRS

Authors: Nathan Cheng, Debra Fromer

Published in: Current Bladder Dysfunction Reports | Issue 3/2021

Login to get access

Abstract

Purpose of Review

This review will provide an understanding of the FDA device approval process, particularly with respect to medical devices used in female pelvic medicine and reconstructive surgery.

Recent Findings

Bringing a novel medical device to the market through the FDA regulatory process can be broken down into four steps: device classification, selecting and preparing premarket-submission regulatory pathways, FDA review of premarket-submissions, and postmarket regulatory controls.

Summary

While the FDA regulatory process can be daunting, physicians and surgeons have the responsibility toward unmet needs of patients and should be at the helm of medical device innovation.
Literature
1.
go back to reference Fox C, Fromer D. Trends in innovation in the surgical management of stress incontinence and pelvic organ prolapse: a “deep dive” into the FDA 510(k) and Premarket Approval Databases. American Urological Association National Meeting. (2020). Fox C, Fromer D. Trends in innovation in the surgical management of stress incontinence and pelvic organ prolapse: a “deep dive” into the FDA 510(k) and Premarket Approval Databases. American Urological Association National Meeting. (2020).
2.
go back to reference U.S. Food and Drug Administration. Center for Devices and Radiologic Health. Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. DC: Washington; 2011. www.fda.gov/media/81123/download U.S. Food and Drug Administration. Center for Devices and Radiologic Health. Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. DC: Washington; 2011. www.​fda.​gov/​media/​81123/​download
3.
go back to reference Obstetrical and Gynecological Devices; Reclassification of surgical mesh for transvaginal pelvic organ prolapse repair. 21 C.F.R. §884 (2016). Obstetrical and Gynecological Devices; Reclassification of surgical mesh for transvaginal pelvic organ prolapse repair. 21 C.F.R. §884 (2016).
6.
go back to reference U.S. Food and Drug Administration. Center for Devices and Radiologic Health. Medical Device Classification Product Codes: Guidance for Industry and Food and Drug Administration Staff. DC: Washington; 2013. www.fda.gov/media/82781/download* U.S. Food and Drug Administration. Center for Devices and Radiologic Health. Medical Device Classification Product Codes: Guidance for Industry and Food and Drug Administration Staff. DC: Washington; 2013. www.​fda.​gov/​media/​82781/​download*
10.
go back to reference Premarket Approval of Medical Devices, 21 C.F.R § 814 (2020). Premarket Approval of Medical Devices, 21 C.F.R § 814 (2020).
14.
go back to reference United States Government Accountability Office. Report to the Ranking Member, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, Committee on Appropriations, House of Representatives: Medical Devices: FDA Ordered Postmarket Studies to Better Understand Safety Issues, and Many Studies Are Ongoing. GAO-15-815 https://www.gao.gov/assets/gao-15-815.pdf, Sept 2015. United States Government Accountability Office. Report to the Ranking Member, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, Committee on Appropriations, House of Representatives: Medical Devices: FDA Ordered Postmarket Studies to Better Understand Safety Issues, and Many Studies Are Ongoing. GAO-15-815 https://​www.​gao.​gov/​assets/​gao-15-815.​pdf, Sept 2015.
16.
go back to reference Reynolds IS, Rising JP, Coukell AJ, et al. Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies. JAMA Intern Med. 2014;174:1773–9.CrossRef Reynolds IS, Rising JP, Coukell AJ, et al. Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies. JAMA Intern Med. 2014;174:1773–9.CrossRef
17.
go back to reference Wimmer NJ, Robbins S, Ssemaganda H, et al. Assessing the cost burden of United States FDA-mandated post-approval studies for medical devices. J Health Care Finance. 2016. Wimmer NJ, Robbins S, Ssemaganda H, et al. Assessing the cost burden of United States FDA-mandated post-approval studies for medical devices. J Health Care Finance. 2016.
Metadata
Title
Understanding the FDA Device Approval Process in FPMRS
Authors
Nathan Cheng
Debra Fromer
Publication date
01-09-2021
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports / Issue 3/2021
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-021-00630-7

Other articles of this Issue 3/2021

Current Bladder Dysfunction Reports 3/2021 Go to the issue

Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors)

Questionnaires to Evaluate Lower Urinary Tract Symptoms in Men and Women

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Contemporary Review of MRI in Benign Genitourinary Pelvic Medicine: What Every Urologist Should Know

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Optimizing Lead Placement in Sacral Neuromodulation

Neurogenic Bladder (C Powell, Section Editor)

Neuroanatomy of Bladder Pain